InsiderTrades.com logo

CNTB Insider Trading

Insider Ownership Percentage: 22.60%
Insider Buying (Last 12 Months): $4,002,000.00
Insider Selling (Last 12 Months): $0.00

Connect Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Connect Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Connect Biopharma Share Price & Price History

Current Price: $2.90
Price Change: ▲ Price Increase of +0.181 (6.65%)
As of 04/2/2026 01:24 PM ET

This chart shows the closing price history over time for CNTB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Connect Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/31/2026James HuangDirectorBuy1,160,000$3.45$4,002,000.0013,160,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Connect Biopharma (NASDAQ:CNTB)

58.72% of Connect Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CNTB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Connect Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Perceptive Advisors LLC792,696$2.24M0.0%N/A1.418%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC47,050$0.13M0.0%N/A0.084%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada40,400$0.11M0.0%N/A0.072%Search for SEC Filing on Google Icon
2/17/2026Persistent Asset Partners Ltd26,774$76K0.0%N/A0.048%Search for SEC Filing on Google Icon
2/16/2026OMERS ADMINISTRATION Corp80,808$0.23M0.0%N/A0.145%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP128,368$0.36M0.0%+121.2%0.230%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC82,226$0.23M0.0%N/A0.147%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP16,785$47K0.0%+60.5%0.030%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC143,100$0.40M0.0%-9.5%0.256%Search for SEC Filing on Google Icon
2/12/2026Knott David M Jr200,000$0.56M0.3%N/A0.358%Search for SEC Filing on Google Icon
2/12/2026Richmond Brothers Inc.173,485$0.49M0.3%N/A0.310%Search for SEC Filing on Google Icon
2/12/2026SmartHarvest Portfolios LLC12,897$36K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/3/2026BML Capital Management LLC408,887$1.15M1.0%-67.7%0.731%Search for SEC Filing on Google Icon
11/10/2025BML Capital Management LLC1,267,500$1.91M1.5%-30.4%2.275%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd28,862$29K0.0%N/A0.052%Search for SEC Filing on Google Icon
8/12/2025AlphaCore Capital LLC80,000$78K0.0%N/A0.144%Search for SEC Filing on Google Icon
8/11/2025BML Capital Management LLC1,821,558$1.79M1.4%-13.0%3.278%Search for SEC Filing on Google Icon
7/29/2025Koa Wealth Management LLC49,600$49K0.0%N/A0.089%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC134,697$0.19M0.0%-23.2%0.244%Search for SEC Filing on Google Icon
2/3/2025Callan Capital LLC80,000$0.11M0.0%+91.3%0.145%Search for SEC Filing on Google Icon
1/27/2025Choreo LLC160,867$0.20M0.0%N/A0.291%Search for SEC Filing on Google Icon
1/24/2025Catalina Capital Group LLC47,867$66K0.0%N/A0.087%Search for SEC Filing on Google Icon
11/5/2024BML Capital Management LLC2,093,232$3.01M1.8%+2.4%3.789%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC212,300$0.32M0.0%-11.5%0.385%Search for SEC Filing on Google Icon
7/17/2024Keudell Morrison Wealth Management32,200$49K0.0%+63.5%0.058%Search for SEC Filing on Google Icon
5/7/2024Keudell Morrison Wealth Management19,700$34K0.0%+75.9%0.036%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743%Search for SEC Filing on Google Icon
8/15/2023Kynam Capital Management LP535,005$0.60M0.1%-27.7%0.972%Search for SEC Filing on Google Icon
11/14/2022Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049%Search for SEC Filing on Google Icon
8/16/2022DAFNA Capital Management LLC250,000$0.22M0.1%N/A0.454%Search for SEC Filing on Google Icon
5/13/2022Kynam Capital Management LP227,759$0.69M0.2%N/A0.414%Search for SEC Filing on Google Icon
2/22/2022DLD Asset Management LP121,707$0.63M0.0%N/A0.212%Search for SEC Filing on Google Icon
2/15/2022DLD Asset Management LP121,707$0.63M0.0%N/A0.212%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP175,000$0.90M0.2%N/A0.304%Search for SEC Filing on Google Icon
2/14/2022Deep Track Capital LP647,057$3.33M0.2%N/A1.125%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc25,412$0.13M0.0%N/A0.044%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Connect Biopharma logo
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California.
Read More on Connect Biopharma

Today's Range

Now: $2.90
Low: $2.72
High: $2.92

50 Day Range

MA: $2.70
Low: $2.30
High: $3.69

52 Week Range

Now: $2.90
Low: $0.51
High: $3.82

Volume

444,044 shs

Average Volume

168,553 shs

Market Capitalization

$162.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Connect Biopharma?

Connect Biopharma's top insider investors include:
  1. James Huang (Director)
Learn More about top insider investors at Connect Biopharma.